Abstract
Despite numerous studies, there is still no clear idea on the fine mechanisms of dysfunction of the brain dopamine system during the formation of alcohol dependence. In this work, we studied the expression of genes that encode tyrosine hydroxylase (TH), a key enzyme of dopamine synthesis, dopamine transporter (DAT), dopamine receptors of the second subtype (DRD2) in the midbrain, and dopamine receptors of the first and second subtypes (DRD1 and DRD2) in the striatum of rats that consumed alcohol from the 60th to 120th days of life in the “free choice” paradigm. The most pronounced changes, a decrease in mRNA expression of DRD1 and DRD2 in the striatum, as well as DAT and TH in the midbrain, were observed in animals with a growing preference for alcohol compared to a group of rats that controlled consumption at a constantly low level. In animals with initially stable high levels of alcohol preference, a decrease in the relative expression level of DRD1 and DRD2 mRNA in the striatum was found, while there was no difference in the expression of DAT and TH mRNA in the midbrain. The expression level of DRD2 mRNA in the midbrain did not differ in all the studied groups. These data suggest that changes in the expression of mRNA of DRD1 and DRD2 in the striatum do not depend on the initial alcohol preference and are determined by the level of alcohol intoxication, while the decrease in the level of TH and DAT mRNA in the midbrain may be one of the mech-anisms of loss of control over consumption.
Similar content being viewed by others
References
Anokhina, I.P. and Shamakina, I.Yu., in Rukovodstvo po narkologii (Manual on Narcology), Ivanets, N.N., Anokhina, I.P., Vinnikova, M.A., Eds., Moscow: GEOTAR-Media, 2016, pp. 96–115.
Blum, K., Thanos, P.K., Oscar-Berman, M., Febo, M., Baron, D., Badgaiyan, R.D., Gardner, E., Demetrovics, Z., Fahlke, C., Haberstick, B.C., Dushaj, K., and Gold, M.S., Journal of Reward Deficiency Syndrome, 2015, vol. 1, no. 3, pp. 95–104.
Tye, K.M., Mirzabekov, J.J., Warden, M.R., Ferenczi, E.A., Tsai, H.C., Finkelstein, J., Kim, S.Y., Adhikari, A., Thompson, K.R., Andalman, A.S., Gunaydin, L.A., Witten, I.B., and Deisseroth, K., Nature, 2013, vol. 493, pp. 537–541.
Lammel, S., Tye, K.M., and Warden, M.R., Genes, Brain and Behavior, 2014, vol. 13, pp. 38–51.
Ikemoto, S., Yang, C., and Tan, A., Behavioural Brain Research, 2015, vol. 290, pp. 17–31.
Ashok, A.H., Marques, T.R., Jauhar, S., Nour, M.M., Goodwin, G.M., Young, A.H., and Howeset, O.D., Molecular Psychiatry, 2017, vol. 22, no. 5, pp. 666–679.
Belujon, P. and Grace, A.A., Int. J. Neuropsychopharmacol., 2017, vol. 20, no. 12, pp. 1036–1046.
Blum, K., Thanos, P.K., Wang, G.J., Febo, M., Demetrovics, Z., Modestino, E.J., Braverman, E.R., Baron, D., Badgaiyan, R.D., and Gold, M.S., Curr. Pharm. Des, 2018, vol. 23, no. 39, pp. 6050–6061.
Most, D., Ferguson, L., and Harris, R.A., Handbook of Clinical Neurology, 2014, vol. 125, pp. 89–111.
Morganstern, I. and Tejani-Butt, S., Neurochemical Research, vol. 35, no. 11, pp. 1708–1715.
Hirth, N., Meinhardt, M.W., Noori, H.R., Salgado, H., Torres-Ramirez, J., Uhrig, S., Broccoli, L., Vengeliene, V., Roßmanith, M., Perreau-Lenz, S., Kohr, G., Sommer, W.H., Spanagel, R., and Hansson, A.C., Proc. Natl. Acad. Sci. U. S. A., 2016, vol. 113, no. 11, pp. 3024–3029.
Koob, G.F. and Volkow, N.D., Neuropsychopharmacology, 2010, vol. 35, no. 1, pp. 217–238.
Diana, M., Front. Psychiatry, 2011, vol. 2, p. 64.
Tupala, E. and Tiihonen, J., Brain Res., 2005, vol. 1031, no. 1, pp. 20–29.
Bice, P.J., Liang, T., Zhang, L., Strother, W.N., and Carr, L.G., Mamm. Genome, 2008, vol. 19, pp. 69–76.
Spiga, S., Talani, G., Mulas, G., Licheri, V., Fois, G.R., Muggironi, G., Masala, N., Cannizzaro, C., Biggio, G., Sanna, E., and Diana, M., Proc. Natl. Acad. Sci. U. S. A., 2014, vol. 111, no. 35, pp. E3745–E3754.
Tiihonen, J., Vilkman, H., Räsänen, P., Ryynänen, O.P., Hakko, H., Bergman, J., Hämäläinen, T., Laakso, A., Haaparanta-Solin, M., Solin, O., Kuoppamäki, M., Syvälahti, E., and Hietala, J., Mol. Psychiatry, 1998, vol. 3, no. 2, pp. 156–161.
Kawahata, I., Evelyn, G.R., Huinan, X., Ohtaku, S., Tomioka, Y., and Yamakuni, T., Neuro. Endocrinol. Lett., 2017, vol. 38, no. 1, pp. 43–49.
Rothblat, D.S., Rubin, E., and Schneider, J.S., Neurosci. Let., 2001, vol. 300, no. 2, pp. 63–66.
Siciliano, C.A., Locke, J.L., Mathews, T.A., Lopez, M.F., Becker, H.C., and Jones, S.R., Alcohol, 2017, vol. 58, pp. 25–32.
Carroll, M.R., Rodd, Z.A., Murphy, J.M., and Simon, J.R., Alcohol, 2006, vol. 40, no. 2, pp. 103–109.
Jiao, X., Paré, W.P., and Tejani-Butt, S.M., Brain Res., 2006, vol. 1073–1074, pp. 175–182.
Weiss, F., Parsons, L.H., Schulteis, G., Hyytia, P., Lorang, M.T., Bloom, F.E., and Koob, G.F., J. Neurosci., 1996, vol. 16, no. 10, pp. 3474–3485.
Cooper, J., Bloom, F., and Roth, R., The Biochemical Basis of Neuropharmacology, Oxford, UK: Oxford Univ. Press, 2003, p. 8.
Dumartin, B., Jaber, M., Gonon, F., Caron, M.G., Giros, B., and Bloch, B., Proc. Natl. Acad. Sci. USA, 2000, vol. 97, no. 4, pp. 1879–1884.
Vengeliene, V., Bespalov, A., Roßmanith, M., Horschitz, S., Berger, S., Relo, A.L., Noori, H.R., Schneider, P., Enkel, T., Bartsch, D., Schneider, M., Behl, B., Hansson, A.C., Schloss, P., and Spanagel, R., Disease Models & Mechanisms, 2017, vol. 10, no. 4, pp. 451–461.
Tapocik, J.D., Solomon, M., Flanigan, M., Meinhardt, M., Barbier, E., Schank, J.R., Schwandt, M., Sommer, W.H., and Heilig, M., The Pharmacogenomics Journal, 2013, vol. 13, no. 3, pp. 286–296.
Heilig, M., Barbier, E., Johnstone, A.L., Tapocik, J., Meinhardt, M.W., Pfarr, S., Wahlestedt, C., and Sommer, W.H., Genes, Brain, and Behavior, 2017, vol. 16, no. 1, pp. 86–100.
Sommer, W.H., Rimondini, R., Hansson, A.C., Hips-kind, P.A., Gehlert, D.R., Barr, C.S., and Heilig, M.A., Biol. Psychiatry, 2008, vol. 63, no. 2, pp. 139–145.
Feltman, K., Borroto-Escuela, D.O., Ruegg, J., Pinton, L., de Oliveira, SergioT., Narvaez, M., Jimenez-Beristain, A., Ekstr, T.J., Fuxe, K., and Steensland, P., Alcoholism: Clinical and Experimental Research, vol. 42, no. 2, pp. 338–351.
Chen, X., Xu, L., Radcliffe, P., Sun, B., and Tank, A.W., Molecular Pharmacology, 2008, vol. 73, no. 6, pp. 1816–1828.
Galleguillos, D., Fuentealba, J.A., Gomez, L.M., Saver, M., Gomez, A., Nash, K., Burger, C., Gysling, K., and Andreas, M.A.J., J. Neurochem., 2010, vol. 114, pp. 1158–1167.
Zhang, Y., Zhu, X., Bai, M., Zhang, L., Xue, L., and Yi, J., PLoS One, 2013, vol. 8, no. 7, p. e69934.
Olszewski, P.K., Grace, M.K., and Fard, S.S., Le Greves, M., Klockars, A., Massi, M., Schioth, H.B., and Levine, A.S, Am. J. Physiol. Regul. Integr. Comp. Physiol., 2010, vol. 299, pp. R655–R663.
Livak, K.J. and Schmittgen, T.D., Methods, 2001, vol. 25, no. 4, pp. 402–408.
Green, A.S. and Grahame, N.J., Alcohol (Fayetteville, NY), 2008. vol. 42, no. 1, pp. 1–11.
Bjorklund, A. and Dunnett, S.B., Trends Neurosci., 2007, vol. 30, no. 5, pp. 194–202.
Smith, Y. and Villalba, R., Mov. Disord., 2008, no. Suppl. 3, pp. 534–547.
Scott, S.S., Gervasi, N.M., and Kaplan, B.B., Trends Cell. Mol. Biol, 2015, vol. 10, pp. 1–36.
Holt, C.E. and Schuman, E.M., Neuron, 2013, vol. 80, no. 3, pp. 648–657.
Crispino, M., Chun, J.T., Cefaliello, C., Perrone, Capano C., and Giuditta, A., Dev. Neurobiol, 2014, vol. 74, no. 3, pp. 279–291.
Melia, K.R., Trembleau, A., Oddi, R., Sanna, P.P., and Bloom, F.E., Exp. Neurol., 1994, vol. 130, no. 2, pp. 394–406.
Gervasi, N.M., Scott, S.S., Aschrafi, A., Gale, J., Vohra, S.N., MacGibeny, M. A., Kar, A.N., Gioio, A.E., and Kaplan, B.B, RNA, 2016, vol. 22, no. 6, pp. 883–895.
Nutt, D.J., Lingford-Hughes, A., Erritzoe, D., and Stokes, P.R., Nat. Rev. Neurosci., 2015, vol. 16, no. 5, pp. 305–312.
Volkow, N.D., Wang, G.J., Telang, F., Fowler, J.S., Logan, J., Jayne, M., Ma, Y., Pradhan, K., and Wong, C., J. Neurosci., 2007, vol. 27, no. 46, pp. 12700–12706.
Beck, A., Schlagenhauf, F., Wüstenberg, T., Hein, J., Kienast, T., Kahnt, T., Schmack, K., Hägele, C., Knutson, B., Heinz, A., and Wrase, J., Biol. Psychiatry, 2009, vol. 66, no. 8, pp. 734–742.
Beaulieu, J.-M. and Gainetdinov, R.R., Pharmacological Reviews, 2011, vol. 63, no. 1, pp. 182–217.
Chefer, V.I., Backman, C.M., Gigante, E.D., and Shippenberg, T.S., Neuropsychopharmacology, 2013, vol. 38, no. 13, pp. 2623–2631.
Lalanne, L., Ayranci, G., Kieffer, B.L., and Lutz, P.-E., Frontiers in Psychiatry, 2014, vol. 5, p. 170.
Shagiakhmetov, F.Sh., Proskuryakova, T.V., and Shamakina, I.Yu., Neirokhimiya, 2015, vol. 32, no. 4, p. 285–294.
Author information
Authors and Affiliations
Corresponding author
Additional information
Russian Text © The Author(s), 2019, published in Neirokhimiya, 2019, Vol. 36, No. 2, pp. 119–127.
Rights and permissions
About this article
Cite this article
Anokhin, P.K., Razumkina, E.V. & Shamakina, I.Y. A Comparison of mRNA Expression of Dopamine Receptors, Tyrosine Hydroxylase, and Dopamine Transporter in the Mesolimbic System of Rats with Different Levels of Alcohol Consumption. Neurochem. J. 13, 137–144 (2019). https://doi.org/10.1134/S1819712419010033
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1819712419010033